Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Background

Juvenile idiopathic arthritis pathogenesis involves a large number of different immune system cells, which are both sources and targets of chemokines, that affect not only their migration but also survival, proliferation, differentiation, production of all cytokine types, degranulation, and also directly stimulating or suppressing angiogenesis. Studyingthe contribution of chemokines to this disease pathogenesis will make it possible to identify new sensitive and specific markers for its diagnosis and subsequent dynamic monitoring of treatment effectiveness.

Aims

The study aimed to identify a list of the most informative diagnostic markers from a wide range of juvenile idiopathic arthritis patients' blood plasma chemokines.

Methods

The case-control study included 40 diagnosed pathology patients and 20 healthy age- matched children. The content of MCP-1/CCL2, MCP-3/CCL7, MIG/CXCL9, MIP-1α/CCL3, MIP-1β/CCL4, RANTES/CCL5, IFN-γ, IP-10/CXCL10, and MDC/CCL22 were measured by enzyme-linked immunosorbent assay in blood plasma of each person.

Results

The following chemokines were included in the list of the most promising diagnostic markers: MCP-1, MIP-1α, MIG, RANTES, and IFN-γ. Their blood plasma content in patients with a diagnosed pathology was from 3 to 60 times (MIG) higher than in the conditionally healthy group. Their sensitivity and specificity exceeded 90%.

Conclusion

An increase in their content leads to active monocytes/macrophages migration to the site of inflammation, where they suppress effector T-cell activity by binding suppressor exosomes and activate B-cells by autoantigens presentation received due to joint tissue destruction. This allows us to speak about the predominance of the Th1-mediated immune response during the development of studied disease chronic inflammation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971308074240813060452
2024-09-05
2025-09-04

  • From This Site

    /content/journals/crr/10.2174/0115733971308074240813060452
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MartiniA. LovellD.J. AlbaniS. BrunnerH.I. HyrichK.L. ThompsonS.D. RupertoN. Juvenile idiopathic arthritis.Nat. Rev. Dis. Primers202281510.1038/s41572‑021‑00332‑835087087
     [Google Scholar]
  2. ConsolaroA. RupertoN. BazsoA. PistorioA. Magni-ManzoniS. FilocamoG. MalattiaC. ViolaS. MartiniA. RavelliA. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.Arthritis Care Res.200961565866610.1002/art.2451619405003
     [Google Scholar]
  3. HughesC.E. NibbsR.J.B. A guide to chemokines and their receptors.FEBS J.2018285162944297110.1111/febs.1446629637711
     [Google Scholar]
  4. MatsushimaK. Chemokines. IntroductionSpringer Semin. Immunopathol.200022432132810.1007/s00281000004911155439
     [Google Scholar]
  5. van der VorstE.P.C. DöringY. WeberC. Chemokines.Arterioscler. Thromb. Vasc. Biol.20153511e52e5610.1161/atvbaha.115.30635926490276
     [Google Scholar]
  6. Bulatović CalasanM. de VriesL.D. VastertS.J. HeijstekM.W. WulffraatN.M. Interpretation of the Juvenile Arthritis Disease Activity Score: Responsiveness, clinically important differences and levels of disease activity in prospective cohorts of patients with juvenile idiopathic arthritis.Rheumatology (Oxford)201453230731210.1093/rheumatology/ket31024162034
     [Google Scholar]
  7. LinY.T. WangC.T. GershwinM.E. ChiangB.L. The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis.Autoimmun. Rev.201110848248910.1016/j.autrev.2011.02.00121320644
     [Google Scholar]
  8. BresciaA.C. SimondsM.M. SullivanK.E. RoseC.D. Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis.Proteomics Clin. Appl.2017115-6160008810.1002/prca.20160008828012239
     [Google Scholar]
  9. KostikM.M. MakhovaM.A. MaletinA.S. MagomedovaS.M. SorokinaL.S. TsukasakiM. OkamotoK. TakayanagiH. VasilievD.S. KozlovaD.I. MushkinA.Y. Cytokine profile in patients with chronic non-bacterial osteomyelitis, juvenile idiopathic arthritis, and insulin-dependent diabetes mellitus.Cytokine202114315552110.1016/j.cyto.2021.15552133863633
     [Google Scholar]
  10. AilioaieL.M. AilioaieC. LitscherG. Biomarkers in systemic juvenile idiopathic arthritis, macrophage activation syndrome and their importance in COVID era.Int. J. Mol. Sci.202223211275710.3390/ijms23211275736361547
     [Google Scholar]
  11. MizutaM. ShimizuM. InoueN. NakagishiY. YachieA. Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome.Cytokine201911918218710.1016/j.cyto.2019.03.01830952065
     [Google Scholar]
  12. TokunagaR. ZhangW. NaseemM. PucciniA. BergerM.D. SoniS. McSkaneM. BabaH. LenzH.J. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy.Cancer Treat. Rev.201863404710.1016/j.ctrv.2017.11.00729207310
     [Google Scholar]
  13. PezzanoM. MIG in autoimmune thyroiditis: Review of the literature.Clin. Ter.20191704e295e30010.7417/CT.2019.215131304519
     [Google Scholar]
  14. WhitingD. HsiehG. YunJ.J. BanerjiA. YaoW. FishbeinM.C. BelperioJ. StrieterR.M. BonavidaB. ArdehaliA. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.J. Immunol.2004172127417742410.4049/jimmunol.172.12.741715187119
     [Google Scholar]
  15. DajotoyT. AnderssonP. BjartellA. LöfdahlC.G. TapperH. EgestenA. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-γ.J. Leukoc. Biol.200476368569110.1189/jlb.080337915197236
     [Google Scholar]
  16. LoetscherP. PellegrinoA. GongJ.H. MattioliI. LoetscherM. BardiG. BaggioliniM. Clark-LewisI. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3.J. Biol. Chem.200127652986299110.1074/jbc.M00565220011110785
     [Google Scholar]
  17. GodiskaR. ChantryD. RaportC.J. SozzaniS. AllavenaP. LevitenD. MantovaniA. GrayP.W. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells.J. Exp. Med.199718591595160410.1084/jem.185.9.15959151897
     [Google Scholar]
  18. MantovaniA. GrayP.A. Van DammeJ. SozzaniS. Macrophage-derived chemokine (MDC).J. Leukoc. Biol.200068340040410.1189/jlb.68.3.40010985257
     [Google Scholar]
  19. DeshmaneS.L. KremlevS. AminiS. SawayaB.E. Monocyte chemoattractant protein-1 (MCP-1): An overview.J. Interferon Cytokine Res.200929631332610.1089/jir.2008.002719441883
     [Google Scholar]
  20. MaurerM. von StebutE. Macrophage inflammatory protein-1.Int. J. Biochem. Cell Biol.200436101882188610.1016/j.biocel.2003.10.01915203102
     [Google Scholar]
  21. BonecchiR. SozzaniS. StineJ.T. LuiniW. D’AmicoG. AllavenaP. ChantryD. MantovaniA. Divergent effects of interleukin-4 and interferon-γ on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses.Blood19989282668267110.1182/blood.V92.8.26689763548
     [Google Scholar]
  22. LevyJ.A. The unexpected pleiotropic activities of rantes.J. Immunol.200918273945394610.4049/jimmunol.099001519299688
     [Google Scholar]
  23. LillardJ.W.Jr SinghU.P. BoyakaP.N. SinghS. TaubD.D. McGheeJ.R. MIP-1α and MIP-1β differentially mediate mucosal and systemic adaptive immunity.Blood2003101380781410.1182/blood‑2002‑07‑230512393512
     [Google Scholar]
  24. VillaltaF. ZhangY. BibbK.E. KappesJ.C. LimaM.F. The cysteine-cysteine family of chemokines RANTES, MIP-1α, and MIP-1β induce trypanocidal activity in human macrophages via nitric oxide.Infect. Immun.199866104690469510.1128/IAI.66.10.4690‑4695.19989746565
     [Google Scholar]
  25. MeidaninikjehS. SabouniN. MarzouniH.Z. BengarS. KhaliliA. JafariR. Monocytes and macrophages in COVID-19: Friends and foes.Life Sci.202126911901010.1016/j.lfs.2020.11901033454368
     [Google Scholar]
  26. BurkeJ.D. YoungH.A. IFN-γ: A cytokine at the right time, is in the right place.Semin. Immunol.20194310128010128010.1016/j.smim.2019.05.00231221552
     [Google Scholar]
  27. LoetscherP. UguccioniM. BordoliL. BaggioliniM. MoserB. ChizzoliniC. DayerJ.M. CCR5 is characteristic of Th1 lymphocytes.Nature1998391666534434510.1038/348149450746
     [Google Scholar]
  28. YaoT.C. KuoM.L. SeeL.C. OuL.S. LeeW.I. ChanC.K. HuangJ.L. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile Rheumatoid arthritis: A six-year longitudinal study.Arthritis Rheum.20065482585259310.1002/art.2196216868981
     [Google Scholar]
  29. de JagerW. HoppenreijsE.P A H. WulffraatN.M. WedderburnL.R. KuisW. PrakkenB.J. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: A cross-sectional study.Ann. Rheum. Dis.200766558959810.1136/ard.2006.06185317170049
     [Google Scholar]
  30. PatrickA.E. WangW. BrokampE. GrahamT.B. AuneT.M. DuisJ.B. Juvenile idiopathic arthritis associated with a mutation in GATA3.Arthritis Res. Ther.201921115610.1186/s13075‑019‑1946‑331238969
     [Google Scholar]
  31. PatrickA.E. ShoaffK. EsmondT. PatrickD.M. FlahertyD.K. GrahamT.B. CrookeP.S.III ThompsonS. AuneT.M. Increased development of Th1, Th17, and Th1.17 cells under T1 polarizing conditions in juvenile idiopathic arthritis.Front. Immunol.20221384816810.3389/fimmu.2022.84816835860254
     [Google Scholar]
  32. SpurlockC.F.III TossbergJ.T. GuoY. CollierS.P. CrookeP.S.III AuneT.M. Expression and functions of long noncoding RNAs during human T helper cell differentiation.Nat. Commun.201561693210.1038/ncomms793225903499
     [Google Scholar]
  33. SzekaneczZ. VegvariA. SzaboZ. KochA.E. Chemokines and chemokine receptors in arthritis.Front. Biosci. (Schol. Ed.)2010S2115316710.2741/s5320036936
     [Google Scholar]
  34. MentenP. WuytsA. Van DammeJ. Monocyte chemotactic protein-3.Eur. Cytokine Netw.200112455456011781181
     [Google Scholar]
  35. AliS. RobertsonH. WainJ.H. IsaacsJ.D. MalikG. KirbyJ.A. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine- mediated inflammation.J. Immunol.200517521257126610.4049/jimmunol.175.2.125716002730
     [Google Scholar]
  36. TaubD.D. ProostP. MurphyW.J. AnverM. LongoD.L. van DammeJ. OppenheimJ.J. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.J. Clin. Invest.19959531370137610.1172/JCI1177887883984
     [Google Scholar]
  37. TsouC.L. PetersW. SiY. SlaymakerS. AslanianA.M. WeisbergS.P. MackM. CharoI.F. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.J. Clin. Invest.2007117490290910.1172/JCI2991917364026
     [Google Scholar]
  38. CharoI.F. RansohoffR.M. The many roles of chemokines and chemokine receptors in inflammation.N. Engl. J. Med.2006354661062110.1056/NEJMra05272316467548
     [Google Scholar]
  39. DufourJ.H. DziejmanM. LiuM.T. LeungJ.H. LaneT.E. LusterA.D. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.J. Immunol.200216873195320410.4049/jimmunol.168.7.319511907072
     [Google Scholar]
  40. AbdukhakimovaD. DossybayevaK. AlmukhamedovaZ. MukushevaZ. AssylbekovaM. ZhangabylovaD. NurgaliyevaK. BoluspayevaN. KulmangabetovaK. HasanovaL. TankoM. PoddigheD. Serum immunoglobulin A (IgA) levels in children affected with juvenile idiopathic arthritis.Heliyon202397e1747910.1016/j.heliyon.2023.e1747937483758
     [Google Scholar]
  41. CarlssonE. MidgleyA. PerkinsS. Caamano-GutierrezE. GritzfeldJ.F. BeresfordM.W. HedrichC.M. Serum protein signatures differentiate paediatric autoimmune/inflammatory disorders.Clin. Immunol.202122910879010.1016/j.clim.2021.10879034197952
     [Google Scholar]
/content/journals/crr/10.2174/0115733971308074240813060452
Loading
Specific Features of Juvenile Idiopathic Arthritis Patients’ Chemokine Profile: The Data of Case-Control Study Analysis
Curr. Rheumatol. Rev. 21, 316 (2025); https://doi.org/10.2174/0115733971308074240813060452
/content/journals/crr/10.2174/0115733971308074240813060452
/content/journals/crr/10.2174/0115733971308074240813060452
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): autoimmunity; biomarkers, case-control study; chemokines; cytokine profile; Juvenile idiopathic arthritis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test